文献速递运动医学关节外科

间充质干细胞制备方案与组成的报告情况:骨科临床文献的系统综述

Reporting of Mesenchymal Stem Cell Preparation Protocols and Composition: A Systematic Review of the Clinical Orthopaedic Literature.
PubMed 文献 · Am J Sports Med · 2018-03-19

该系统综述纳入2002至2017年36项临床研究,评估间充质干细胞(MSC)治疗骨科与运动医学疾病的制备与组成报告质量。研究仅报告了52%(范围30%-80%)可能关键影响结局的变量,无研究提供全部变量充分信息。作者鼓励采用新兴的最低报告标准。

要点

  • 57%研究评估骨髓来源MSC,41%评估脂肪来源MSC,2%评估滑膜来源MSC。
  • 研究仅报告52%(范围30%-80%)可能关键影响结局的变量,无研究提供全部变量充分信息。
  • 报告缺陷包括干细胞处理、培养条件和输注细胞群特征的细节不足。

核心结论

  • 所有评估MSC用于骨科或运动医学应用的现有临床研究均受限于制备方案和组成的报告不足。
  • 关键影响结局变量的报告缺陷妨碍结果解读、阻止他人复制实验条件,并使研究间比较困难。
  • 作者鼓励采用新兴的评估骨科MSC临床研究的最低报告标准。

研究设计与样本

  • 系统综述,检索2002至2017年临床骨科和运动医学文献。
  • 纳入标准:人体临床试验、英文发表、涉及骨科或运动医学应用的MSC治疗。
  • 排除标准:体外或离体研究、社论、致编辑信、与美容、神经或牙科应用相关的研究。
  • 初检识别1259项研究,36项符合纳入标准进行综合分析。

主要发现

  • 57%研究评估骨髓来源MSC,41%评估脂肪来源MSC,2%评估滑膜来源MSC。
  • 报告的关键变量存在显著缺陷,包括干细胞处理、培养条件和输注细胞群特征的细节。
  • 总体而言,研究仅报告52%(范围30%-80%)可能关键影响结局的变量。
  • 无研究提供与所有这些变量相关的充分信息。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 所有现有临床研究均受限于制备方案和组成的报告不足。
  • 关键影响结局变量的报告缺陷妨碍结果解读、阻止他人复制实验条件,并使研究间比较困难。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mesenchymal stem cells (MSCs) are increasingly being used in the treatment of a wide variety of sports-related conditions. Despite this enthusiasm, the biological properties of MSCs and their effects on musculoskeletal tissue healing remain poorly understood. MSC-based strategies encompass cell populations with heterogeneous phenotypes isolated from multiple tissues and using different methods. Therefore, comprehensive reporting of the source, preparation methods, and characteristics of MSC strategies is essential to enable interpretation of results. PURPOSE: To perform a systematic review of levels of reporting of key variables in MSC preparation and composition for clinical studies evaluating MSC-based therapies in the treatment of musculoskeletal conditions. STUDY DESIGN: Systematic review. METHODS: A systematic review of the clinical orthopaedic and sports medicine literature from 2002 to 2017 was performed. The following inclusion criteria were used: human clinical trials, published in the English language, involving the administration of MSC-based therapies for orthopaedic or sports medicine applications. In vitro or ex vivo studies, editorials, letters to the editor, and studies relating to cosmetic, neurological, or dental applications were excluded. RESULTS: Of the 1259 studies identified on the initial search, 36 studies were found to satisfy the inclusion criteria for analysis on comprehensive review. Fifty-seven percent of studies evaluated bone marrow-derived MSCs, 41% evaluated adipose-derived MSCs, and 2% evaluated synovium-derived MSCs. Considerable deficiencies in the reporting of key variables, including the details of stem cell processing, culture conditions, and the characteristics of cell populations delivered, were noted. Overall, studies reported only 52% (range, 30%-80%) of variables that may critically influence outcome. No study provided adequate information relating to all of these variables. CONCLUSION: All existing clinical studies evaluating MSCs for orthopaedic or sports medicine applications are limited by inadequate reporting of both preparation protocols and composition. Deficient reporting of the variables that may critically influence outcome precludes interpretation, prevents others from reproducing experimental conditions, and makes comparisons across studies difficult. We encourage the adoption of emerging minimum reporting standards for clinical studies evaluating the use of MSCs in orthopaedics.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Robinson PG, Murray IR, West CC, et al. Reporting of Mesenchymal Stem Cell Preparation Protocols and Composition: A Systematic Review of the Clinical Orthopaedic Literature. Am J Sports Med. 2018. PMID: 29554460. doi:10.1177/0363546518758667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。